Updated overall survival (OS) and progression-free survival (PFS) by blinded independent central review (BICR) of sunitinib (SU) versus placebo (PBO) for patients (Pts) with advanced unresectable pancreatic neuroendocrine tumors (NET) Meeting Abstract

Industry Collaboration International Collaboration

author list

  • Raymond, E., Niccoli, P., Raoul, J., Bang, Y., Borbath, I., Lombard-Bohas, C., Valle, J. W., Metrakos, P., Smith, D., Vinik, A., Chen, J., Hoersch, D., Castellano, D. E., Kennecke, H. F., Picus, J., Van Hazel, G., Lu, D., Chao, R. C., Patyna, S., Van Cutsem, E.

authors

publication date

  • May 20, 2011

webpage

published in

category

volume

  • 29

issue

  • 15